This is an application to become one of the cooperating clinics in the Optic Neuritis Treatment Trial. The ONTT consists of essentially two research components: (1) a clinical trial of the efficacy of oral prednisone and intravenous methylprednisolone in reducing residual optic nerve damage in patient with optic neuritis; and (2) a study of the natural history of optic neuritis. In this proposal we document our patient recruitment potential. Our group of ophthalmologists and neurologists saw 34 patients with optic neuritis meeting the listed study criteria within a 12 month period. The ONTT is chaired by Roy W. Beck, M.D. at the University of South Florida College of Medicine (cooperative agreement award #U01-EY07212-01). The Data Coordinating Center is directed by Patricia Cleary at the Biostatistics Center of George Washington University (cooperative agreement award #U01-EY07460-01).

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01EY007674-01
Application #
3552064
Study Section
Vision Research and Training Committee (VSN)
Project Start
1988-03-01
Project End
1992-02-29
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Wills Eye Hospital (Philadelphia)
Department
Type
DUNS #
073744203
City
Philadelphia
State
PA
Country
United States
Zip Code
19107